60th ANNUAL AUA AWARD WINNERS ANNOUNCED
/PRNewswire/ -- The American Urological Association (AUA) announced today the list of 2023 award recipients. The winners will be recognized at the...
Stay updated with breaking news from Samir Taneja. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The American Urological Association (AUA) announced today the list of 2023 award recipients. The winners will be recognized at the...
2023 Awards Recognize Top Urologists, Honor Service to Specialty and Society BALTIMORE, Dec. 1, 2022 /PRNewswire/ -- The American Urological Assoc...
Published: Apr 19, 2021 BEVERLY HILLS, Calif., April 19, 2021 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural killer (NK) cell engager (TriKE™) protein biologic technology platform, reported financial results for the fourth quarter and year ended December 31, 2020. "2020 was a year of robust clinical progress and milestone achievements for GT Biopharma, which allowed us to accomplish a major corporate milestone in listing GT Biopharma on NASDAQ at the ...